VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair.
Y, W., Y, L., C, Z., & J, G. (2026). VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1844567
Y W, Y L, C Z, J G. VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair.. Frontiers in immunology. 2026; doi: 10.3389/fimmu.2026.1844567
Y W, Y L, C Z, et al. VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair.[J]. Frontiers in immunology. 2026. DOI: 10.3389/fimmu.2026.1844567.
@article{y2026,
author = {Wei Y and Liao Y and Zhang C and Guo J},
title = {VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair.},
journal = {Frontiers in immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1844567},
note = {PMID: 42327765},
}
TY - JOUR AU - Wei Y AU - Liao Y AU - Zhang C AU - Guo J TI - VSMCs and the immune microenvironment: a multidimensional regulatory network driving vascular injury and repair. T2 - Frontiers in immunology PY - 2026 DO - 10.3389/fimmu.2026.1844567 AN - PMID:42327765 ER -
The dynamic interplay between vascular smooth muscle cells (VSMCs) and the immune microenvironment governs vascular repair and disease progression. This review systematically elucidates this multidimensional regulatory network. We primarily dissect the molecular mechanisms driving pathological VSMC remodeling, encompassing inflammatory signaling, regulated cell death, senescence-associated DNA damage, and organelle dysfunction. Furthermore, we delineate the bidirectional crosstalk connecting VSMCs with the extracellular matrix (ECM) and tissue-infiltrating leukocytes, notably macrophages, T cells, and neutrophils. Subsequently, we evaluate how this network dictates disease-specific pathophysiology across various cardiovascular diseases. Specifically, we analyze metabolic reprogramming and epigenetic regulation in atherosclerosis (AS), mechanosensitive inflammation-contraction coupling in hypertension, and kinase-driven organelle stress in aortic aneurysms and dissection. Moreover, we examine the secretory profile of VSMCs in pulmonary arterial hypertension (PAH) and their contribution to microvascular dysfunction in arteritis and cardiomyopathy. Ultimately, we highlight emerging therapeutic strategies targeting VSMC-immune interactions and discuss future translational prospects.